ShareValue scores for 600721.SHG: Valuation 24, Quality 55, Growth 30, Health 57.

600721.SHG
SSE

Xinjiang Baihuacun Co Ltd

CN¥10.54(+10.02%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-7% to 8%
Valuation
24
Overvalued
Price vs Value
Quality
55
Moderate
Business Strength
Growth
30
Weak
Revenue & Earnings
Health
57
Moderate
Financial Stability
Momentum
13
Bearish
Price Trend

Company Details

About

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing, which covers bioanalytical testing, packaging material compatibility, compound structure confirmation, quality studies, and base toxic impurity analysis. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is based in Urumqi, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026